Hypercoagulable States: Diagnosis and Treatment

Thank you

Thank you for joining this webinar.

Description

Presented by Michael Laposata, MD, PhD
University of Texas Medical Branch

This presentation will include a description of the commonly encountered hypercoagulable states. Biochemical mechanisms for each will be presented. Appropriate use of the tests will be explained, and correct interpretation of the tests to assess thrombotic risk will conclude the talk.

Learning Objectives
At the end of this session, the attendee will be able to:

Identify the clinical syndrome of thrombosis
Describe the commonly encountered risk factors for development of thrombosis
Describe the risk factors for thrombosis in pregnancy and the contribution of thrombosis to pregnancy loss

Instruction Level: Intermediate

ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.

Contributors

Michael Laposata, MD, PhD

Dr. Michael Laposata is the Professor and Chair of the Department of Pathology at the University of Texas Medical Branch-Galveston. He received his M.D. and Ph.D. from Johns Hopkins University School of Medicine and completed a postdoctoral research fellowship and residency in Laboratory Medicine (Clinical Pathology) at Washington University School of Medicine in St. Louis. He took his first faculty position at the University of Pennsylvania School of Medicine in Philadelphia in 1985, where he was an Assistant Professor and Director of the hospital's Coagulation Laboratory. In 1989, he became Director of Clinical Laboratories at the Massachusetts General Hospital and was appointed to the faculty in the Department of Pathology at Harvard Medical School, where he became a tenured full Professor of Pathology. Dr. Laposata joined Vanderbilt University School of Medicine in 2008 where he was the Edward and Nancy Fody Professor of Pathology and Medicine. Additionally, he was Pathologist-in-Chief at Vanderbilt University Hospital and Director of Clinical Laboratories.

His basic research program has focused on fatty acids and their metabolites. Dr. Laposata's clinical expertise, for both patient care and clinical research, is in blood coagulation, with a special expertise in diagnostic errors. He has authored more than 200 peer-reviewed publications in basic and clinical research and authored/edited nine books. His work on diagnostic errors earned him an appointment to the 21 member panel of the National Academy of Medicine which issued the 2015 report on Improving Diagnosis in Healthcare.

Dr. Laposata is the recipient of 14 major teaching prizes at Harvard, the Massachusetts General Hospital, and the University of Pennsylvania School of Medicine. His recognitions include the 1989 Lindback Award, a teaching prize with competition across the entire University of Pennsylvania system; the 1998 A. Clifford Barger mentorship award from Harvard Medical School; election to the Harvard Academy of Scholars in 2002, and to the Vanderbilt University School of Medicine Academy for Excellence in Teaching in 2009; and the highest award - by vote of the graduating class - for teaching in years 1 and 2 at Harvard Medical School in 1999, 2000, and 2005.

His textbook, in its third edition, Laposata’s Laboratory Medicine, has been translated into multiple languages. It is used globally by those learning laboratory medicine and those using the clinical laboratory. In a peer nominated survey performed by The Pathologist, a journal reporting on the practice of pathology, the November 2015 issue identified Dr. Laposata as the most influential pathologist in the United States, and the third most influential pathologist in the world.